ロード中...
Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge
Neisseria gonorrhoeae has developed antimicrobial resistance (AMR) to all drugs previously and currently recommended for empirical monotherapy of gonorrhoea. In vitro resistance, including high-level, to the last option ceftriaxone and sporadic failures to treat pharyngeal gonorrhoea with ceftriaxon...
保存先:
| 出版年: | BMC Infect Dis |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4546108/ https://ncbi.nlm.nih.gov/pubmed/26293005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-015-1029-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|